STOP PRICE-FIXING ON GENERIC DRUGS; Congressional Record Vol. 165, No. 82
(House of Representatives - May 16, 2019)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page H3851]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                   STOP PRICE-FIXING ON GENERIC DRUGS

  (Mr. HIGGINS of New York asked and was given permission to address 
the House for 1 minute.)
  Mr. HIGGINS of New York. Mr. Speaker, last week, 44 attorneys general 
filed a lawsuit in Federal court against 20 generic drugmakers, 
alleging market manipulation and price-fixing.
  The American people's tax dollars are invested in unprofitable basic 
research that is essential to bringing highly profitable drugs to 
market. The United States Government is also a huge purchaser of these 
generic drugs.
  In some cases, it is alleged that one company sets the price of a 
drug and the others follow, without the cost-cutting influence of 
competition. All of this resulted in billions of dollars in harm to 
patients and the U.S. economy.
  Congress must stop this price-fixing scheme and will vote this week 
to approve legislation to end this price-fixing and market manipulation 
perpetuated by these generic drugmakers.

                          ____________________